Idéal Investisseur Connexion Connexion
Français English
CAC 40 : Market closed
8 146,83 pts
-0.85%


Last updated : 18/11/2026 - 17h35
🏠 Home   ➤    Stock news

Nanobiotix shares fall 17% in one week, at the bottom of the SBF 120

The Paris-based oncology nanomedicine biotech continues its weekly decline in a market trending downward. The stock is moving clearly away from its medium-term benchmarks, while management has just completed two meetings with the financial community in London.


Nanobiotix shares fall 17% in one week, at the bottom of the SBF 120

A 17% weekly decline that pushes the stock away from its moving averages

Nanobiotix shares closed down 2.51% at €24.08, after falling 5.5% on Monday and 17% over seven days. The stock had nonetheless gained nearly 26% over one month, and this October-November rebound is eroding session after session.

The stock is now below its 20-day moving average (€27.48, a gap of 12.4%), its 50-day moving average (€26.29, a gap of 8.4%) and its 200-day moving average (€29.85, a gap of 19.3%).

The RSI at 40 remains neutral, and the stock ranks in the lower part of the SBF 120 (the largest declines in the index were Alstom, Vusion and Valneva), while the index fell 0.82%. Support at €18.85 is still far away, and resistance at €30.36 is further still.

Cash of €110.9 million announced in September, funding through 2029

The fundamental benchmarks for the case remain those set at the publication of the first-half 2026 results on September 24. The company then indicated it held €110.9 million in cash, enough to fund its operations through 2029. Its NBTXR3 (JNJ-1900) radio-amplifier, combined with radiotherapy, is being developed in partnership with Johnson & Johnson.

On November 16 and 17, management addressed the financial community in London, at the Jefferies and UBS conferences. The stock is also listed on the Nasdaq under the symbol NBTX. Today's session comes amid a marked decline in the CAC 40 (-0.85%) and the SBF 120, against a backdrop of tensions in technology stocks.

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis


Sector Pharmacie et biotechnologies › Biotechnologies


Context

Period
  • Period: S1 2026
Key reported figures
  • Revenue: 3,6 millions d'euros
  • Quarterly revenue: 3,6 millions d'euros
  • Net income: -34,3 millions d'euros
Guidance from the release
  • « la Société estime qu'elle disposera des liquidités suffisantes pour faire face à ses obligations financières […] pendant au moins les 12 prochains mois […] pas de doute substantiel quant à la capacité de la Société à poursuivre son activité » ; CP du 24/09 : trésorerie de 110,9 M€ « permettront de financer ses opérations jusqu'en 2029 »

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
✓ Avant 9h00 ✓ 1000+ inscrits ✓ 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours